In vivo effect of interleukin-1beta and interleukin-1RA on oocyte cytoplasmic maturation, ovulation, and early embryonic development in the mare by Caillaud, Maud et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Reproductive Biology and 
Endocrinology
Open Access Research
In vivo effect of interleukin-1beta and interleukin-1RA on oocyte 
cytoplasmic maturation, ovulation, and early embryonic 
development in the mare
Maud Caillaud, Guy Duchamp and Nadine Gérard*
Address: Physiologie de la Reproduction et des Comportements. INRA-CNRS-Université de Tours-Haras Nationaux, IFR135, 37380 Nouzilly 
France
Email: Maud Caillaud - caillaud@tours.inra.fr; Guy Duchamp - guy.duchamp@tours.inra.fr; Nadine Gérard* - gerard@tours.inra.fr
* Corresponding author    
Abstract
A growing body of evidence suggests that the interleukin-1 system is involved in periovulatory
events. Previous work from our lab demonstrated that in the mare, interleukin-1beta (IL-1beta)
increases the ovulatory rate of metaphase II oocytes. The present study was conducted to analyze
in vivo the effect of IL-1 on oocyte cytoplasmic maturation, ovulation and pregnancy rate. In the
present work, IL-1beta (experiment 1, n = 13; experiment 2, n = 25) and interleukin-1RA (IL-1RA;
experiment 1, n = 25) were injected intrafollicularly by using the transvaginal ultrasound-guided
injection method. Injections were performed on cyclic mares when the diameter of the growing
dominant follicle reached 30–34 mm. In experiment 1, mares were inseminated the day of the
treatment and all the other day until ovulation. The time of ovulation was determined and a
pregnancy diagnosis was performed 14 days after ovulation of the injected follicle. In experiment
2, the cumulus-oocyte complex from each injected follicle was collected by transvaginal ultrasound-
guided aspiration 38 h after the intrafollicular injection. Oocyte nuclear stage and oocyte
cytoplasmic maturation were assessed by analyzing chromatin configuration, cortical granules
migration and mitochondria distribution under a confocal microscope. The results from
experiment 1 confirm that an intrafollicular injection of 1 microgram IL-1beta induces ovulation in
the mare whereas IL-1RA has no effect at the dose used in the present study. Furthemore, we
demonstrated, that in our experimental conditions, IL-1beta and IL-1RA induced a decrease in
embryo development. Experiment 2 leads us to observe that IL-1beta is unable to induce cortical
granules migration and remodelling of mitochondria, that commonly occurs during oocyte
maturation, whereas it acts on nuclear maturation. This result may explain the decrease in embryo
development we observed after IL-1beta intrafollicular injection. In conclusion, the present study
tends to demonstrate that IL-1beta plays a role in the ovulatory process and may acts on oocyte
maturation in the mare, but additional factors are required to complete equine oocyte cytoplasmic
maturation to allow embryo development.
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Background
In recent years, evidence has accumulated to suggest that
cytokines are important regulators of the ovarian func-
tion. Interleukin-1 (IL-1), one major cytokine, as well as
receptors (IL-1R1 and IL-1R2) and antagonist (IL-1RA)
have been demonstrated to be produced in the ovary of
several species [1, for review]. Recently, we demonstrated
the presence of IL-1β  mRNA in equine cumulus-oocyte
complexes and granulosa cells, whereas immunoreactive
IL-1β  has been observed in equine follicular fluids [2,3].
In vitro studies have shown that IL-1β  regulates some cel-
lular activities of granulosa and theca cells, such as ster-
oidogenesis [4,5], as well as synthesis of proteases [6-8]
and prostaglandins [9,10]. Moreover, it has been demon-
strated that IL-1β  promotes the ovulation process in the
rat [11], the rabbit [12] and the mare [13]. IL-1β  increases
in vitro the germinal vesicle breakdown of oocytes in the
rabbit model [12], as well as in vivo in the mare [13],
demonstrating a beneficial role of IL-1β  in oocyte nuclear
maturation. These observations led to conclude that IL-1
may be a paracrine factor that is involved in ovulation and
in oocyte nuclear maturation. In 1994, Takehara et al.,
demonstrated that IL-1β  can facilitate in vitro fertilization
in the rabbit, suggesting that IL-1 may be involved in
oocyte cytoplasmic maturation and could improve fertili-
zation. In the mare, no data is available on the effect of IL-
1β  on oocyte cytoplasmic maturation or fertilization rates.
Nevertheless, a better knowledge of regulating factors
involved in these processes would help to improve the
embryo production in this species.
In this context, the objectives of the present study were to
investigate in vivo in the mare, the potential role of IL-1β
on oocyte cytoplasmic maturation, ovulation and embryo
development.
Materials and methods
Animals and Treatments
All animal procedures were approved by the Agricultural
Agency and Scientific Research Agency (approval number
A37801) and conducted in accordance with guidelines for
Care and Use of Agricultural Animals in Agricultural
Research and Teaching.
Adult cyclic pony mares in good body condition, kept
indoors and fed with concentrates, were used. Mares
received a prostaglandin F2α  analogue (Cloprostenol
[estrumate], 125 µg/mare i.m.; Scherring-Plough, Leval-
lois-Peret, France) during the midluteal phase to induce
luteolysis. Ovarian activity was then assessed by routine
rectal ultrasound scanning. Intrafollicular injections were
performed in the dominant follicle, between 30–34 mm
in diameter, at the end of the follicular phase (see below).
Before intrafollicular injections or punctures, the mares
were sedated with detomidine (0.6 mg/100 kg body
weight [BW] i.v., Domosedan; Pfizer, Amboise, France)
and propantheline bromide (3 mg/100 kg BW i.v.; Sigma,
St. Louis, MO) was administered to achieve rectal relaxa-
tion. After intrafollicular injection or punctures, mares
were treated with an antibiotic (Intramicine, 1 600 000 IU
penicillin/100 kg BW and 1.3 g dihydrostreptomycin/100
kg BW i.m.; Sanofi, Libourne, France).
Crude Equine Gonadotropin (CEG) was prepared from
horse pituitaries that were supplied commercially. The
resulting preparation of CEG contained approximately
6% horse LH and 2–4% horse FSH. An i.v. injection of 15
mg CEG was performed when the diameter of the domi-
nant follicle reached 30–34 mm in order to induce ovula-
tion. Ovulation occurs between 35–40 hours after the
injection [14]
Intrafollicular Injection Procedure
The injection was performed using a transvaginal ultra-
sound-guided system. A 60-cm-long single lumen needle
of 1.1-mm outer diameter was inserted into the dominant
follicle the day it reached 30–34 mm in diameter. Follicu-
lar fluid (2.5 ml) was aspirated in a syringe directly con-
nected to the needle. The studied molecule was diluted in
2 ml of PBS (Dulbecco 'A'; Unipath, Dardilly, France) and
maintained at 37°C. The 2 ml were then injected in the
follicle by using a syringe directly connected to the needle.
Follicular fluid (0.5 ml) from the first syringe was then
injected back into the follicle to rince the needle and rees-
tablish the initial follicular volume.
Experimental Designs
In experiment 1, 61 cyclic mares were used. They were
divided into five groups. Mares from the first group (neg-
ative control group; n = 12) received an intrafollicular
injection (i.f.) of 2 ml of PBS and an jugular injection
(i.v.) of 5 ml of saline. Mares from the second group (IL-
1RA group; n = 12) received an i.f. injection of 2 ml of
recombinant human interleukin-1RA (2.5 µg/ml in PBS,
rhIL-1RA; R&D System, Abingdon, UK) and an i.v. injec-
tion of 5 ml of saline. Mares from the third group (IL-1β
group; n = 13) received an i.f. injection of 2 ml of recom-
binant human IL-1β  (0.5 µg/ml in PBS, rhIL-1β ; R&D Sys-
tem) and an i.v. injection of 5 ml of saline. Mares from the
fourth group (positive control group; n = 12) received an
i.f. injection of 2 ml of PBS and an i.v. injection of 15 mg
CEG in 5 ml of saline. Mares from the last group (IL-1RA/
CEG group; n = 13) received an i.f. injection of 2 ml of
recombinant human interleukin-1RA (2.5 µg/ml in PBS,
rhIL-1RA) and an i.v. injection of 15 mg CEG in 5 ml of
saline.
In experiment 2, 63 cyclic mares were used. They were
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(positive control group; n = 23) received an i.f. injection
of 2 ml of PBS and an i.v. injection of 15 mg CEG in 5 ml
of saline. Mares from the second group (IL-1β  group; n =
25) received an i.f. injection of 2 ml of recombinant
human IL-1β  (0.5 µg/ml in PBS, rhIL-1β ; R&D System)
and an i.v. injection of 5 ml of saline. Mares from the last
group (negative control group; n = 15) received an i.f.
injection of 2 ml of PBS and an i.v. injection of 5 ml of
saline.
Artificial insemination, Detection of Ovulation and 
Pregnancy Diagnosis
Mares from experiment 1 were inseminated with fresh
semen collected from a fertile stallion, using 200 × 106
spermatozoa per insemination. Inseminations were per-
formed on the day of the intrafollicular injection, on the
day after and every 2 days until ovulation of the injected
follicle. Ovulation was assessed ultrasonographically
twice a day from 8 h after the intrafollicular injection until
ovulation (i.e., absence of a large dominant follicle and
presence of a corpus luteum). Fourteen days after ovula-
tion, pregnancy diagnosis was performed by routine ultra-
sonography of the uterus.
Cumulus Oocyte Complex (COC) Recovery and Analysis
COCs were collected from injected follicles of experiment
2. Transvaginal ultrasound-guided aspiration was used 38
h after the intrafollicular injection, as previously described
[15]. Briefly, a single lumen needle (1.8-mm outer diam-
eter) was used to aspirate follicular fluid. The follicle was
then flushed several times with PBS containing heparin
(2.5 IU/ml; LEO S.A., St Quentin Yvelines, France) at
37°C and scraped with the needle in order to pick up the
oocyte. All aspirated fluids were examined with a stereom-
icroscope for oocyte recovery. Cumulus cells were
removed from the oocytes by repeated pipetting and sub-
sequent treatment with 1% hyaluronidase (type III,
875IU/mg; Sigma, La Verpillère, France). Oocytes were
then incubated for 30 min at 37°C in PBS containing 3%
BSA and 280 nM MitoTracker Orange CMTM Ros (Molec-
ular Probes, Oregon, USA) for mitochondria detection.
Then, oocytes were washed three times in pre-warmed
PBS without BSA. The oocytes were then fixed for 20 min
at 37°C using freshly prepared 2.5 % paraformaldehyde
in PBS. After fixation, the oocytes were washed three times
in PBS. The oocytes were then permeabilized in Triton X-
100 (Sigma), 0.1% in PBS, for 5 min at room temperature
and washed in PBS. Oocytes were then incubated for 30
min at room temperature in 100 µg/ml of fluorescein iso-
thiocyanate-conjugated peanut agglutinin in washing
solution (PBS containing 0.05 % NaN3 and 1 mM PMSF)
to detect distribution of cortical granules. After rinsing,
oocytes were stained with 1 µg/ml  bis-benzimide
(Hoechst 33342; Sigma) in PBS for 6 min at room temper-
ature for DNA detection. They were then mounted
between slide and cover slide in a mixture of Moviol V4–
88 (133 mg/ml; Hoechst, Frankfurt, Germany) and n-pro-
pyl gallate (5 mg/ml; Sigma). The slides were kept at 4°C
in darkness until observation. The oocytes were observed
under a confocal laser scanning microscope (Olympus,
France). Mitochondria and cortical granules labelling
were visualized in the confocal mode, whereas Hoechst
staining was detected by conventional epifluorescence.
For fluorescein, an argon ion laser adjusted at 525-nm
emission wave length was used; for MitoTracker Orange
CMTM Ros, a helium-neon ion laser adjusted at 576-nm
was used.
Statistical analysis
The nonparametric tests of Kruskal-Wallis and Wilcoxon-
Mann-Withney were performed using StatXact 5 software
(CYTEL, Cambridge, MA http://www.cytel.com) in order
to compare time of ovulation and percentage of embryos.
The corrected chi-square test was used to compare oocyte
in vivo maturation rates.
Results
Experiment 1: Effect of IL-1β  and IL-1RA intrafollicular 
injection on ovulation and embryo development
During this experiment, 61 follicles were injected. Twelve
to thirteen mares were used per group, in 5 groups.
Time of ovulation
Time of ovulation after intrafollicular injection of PBS, IL-
1β  or IL-1RA was determined by ultrasonography. We
determined three intervals during which the mares ovu-
lated: between 20 and 31 h, between 31 and 47 h, and
more than 47 h after the intrafollicular injection. Figure 1
illustrates the ovulation profiles after intrafollicular injec-
tion of PBS (2 ml), IL-1β  (1 µg/2 ml), or IL-1RA (5 µg/2
ml). In the positive control group (PBS i.f., CEG i.v.),
mares ovulated mainly between 31 and 47 h after the
intrafollicular injection (7/12). Mares from the IL-1β
group (IL-1β  i.f., saline i.v.) ovulated mainly in the same
interval (9/13). The distribution of the time of ovulation
was not significantly different between these two groups.
In the negative control group (PBS i.f., saline i.v.), most of
the mares ovulated more than 47 h after the i.f. injection
(11/12). The IL-1RA group (IL-1RA i.f., saline i.v.) dis-
played a similar distribution of time of ovulation (11/12
ovulations after 47 h). This distribution was significantly
different from that of the positive control group (p <
0.002) and IL-1β  group (p < 0.001). In the IL-1RA/CEG
group (IL-1RA i.f., CEG i.v.), the length of time from injec-
tion to ovulation was heterogeneous. Half of the mares
(6/13) ovulated between 31 and 47 h after the i.f. injec-
tion, whereas 2/13 ovulated during the first interval (20–
31 h) and 5/13 ovulated more than 47 h after the i.f. injec-
tion. This distribution was not significantly different from
that of the positive control group and IL-1β  group butReproductive Biology and Endocrinology 2005, 3:26 http://www.rbej.com/content/3/1/26
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differed significantly from the negative control group and
the IL-1RA group (p < 0.01 each).
Embryo development
Presence or absence of an embryo was determined in each
mare by ultrasonography 14 days after ovulation. Table 1
illustrates the percentage of embryos observed after intra-
follicular injection of PBS (2 ml), IL-1β  (1 µg/2 ml), or IL-
1RA (5 µg/2 ml) coupled to an intraveneous injection of
either saline or CEG. The percentage of embryos was the
same in the two control groups (67%). In contrast, the
percentage of embryos was lower in the three other groups
(25%, 23%, 23%) which received IL-1β  or IL-1RA intra-
follicularly. These lower percentages are not statistically
different from one to the other but are significantly differ-
ent from that of both control groups (p < 0.05).
Length of time from injection to ovulation after intrafollicular administration of IL-1β  or IL-1RA in equine dominant follicles Figure 1
Length of time from injection to ovulation after intrafollicular administration of IL-1β  or IL-1RA in equine dominant follicles. 
For each group, histograms represent the percentage of mares that ovulated during each time interval. The proportion of 
mares is indicated on the top of each histogram. The distribution of the time of ovulation was not significantly different 
between the positive control group and the IL-1β  group. In the negative control group and in the IL-1RA group, the distribu-
tion of the time of ovulation was significantly different from that in the positive control group and in the IL-1β  group. In the IL-
1RA/CEG group, this distribution was not significantly different from that in the positive control group and the IL-1β  group but 
differed significantly from that in the negative control group and in the IL-1RA group.
PBS i.f. - physiological serum i.v. (negative control group)
IL-1RA i.f. - physiological serum i.v. (group IL-1RA)
IL-1β i.f. - physiological serum i.v. (group IL-1β)
PBS i.f. - CEG i.v. (positive control group)
IL-1RA i.f. - CEG i.v. (group IL-1RA/CEG)
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Experiment 2: Effect of IL-1β  on oocyte nuclear and 
cytoplasmic maturation
Cumulus Oocyte Complex recovery and Oocyte nuclear
stage at recovery
In this experiment, 3 groups were constituted: positive
control group, IL-1β  group, negative control group.
Twenty three to 25 mares were used in the 2 first groups
and 15 mares were used in the third group. Out of the
sixty three injected follicles that were punctured, 52
oocytes were collected and analyzed. This corresponds to
82.5% of collection rate. The collection rate was similar in
each group (table 2). All aspirated COCs had expanded
cumuli.
As shown in Table 2, the rate of oocytes that display
resumption of meiosis was significantly higher in the pos-
itive control group (PBS i.f., CEG i.v.) than in the negative
control group (PBS i.f., saline i.v.; p < 0.04). The other
oocytes were either immature or degenerated. Moreover,
60% of oocytes from the IL-1β  group display resumption
of meiosis, that tends (p < 0,1) to be higher than that in
the negative control group.
Cortical granules localization and Mitochondria distribution
Mature (MII) oocytes were analyzed in order to visualize
cortical granules and mitochondria. Thirteen matures
oocytes from the positive control group were analyzed.
Cortical granules migration was achieved or in progress in
most oocytes from this group (8/13), with cortical gran-
ules lining the oolemma (Figure 2A). In the 5 other
oocytes from this group, cortical granules were located in
the medullary zone. In 3 to 5 mature oocytes analyzed
from the IL-1β  group, cortical granules had an uniform
distribution between the oolemma and the medullary
zone (Figure 2B), and only 2 oocytes displayed cortical
granules migration in progress.
In most oocytes from the positive control group (9/13),
the distribution of mitochondria was heterogeneous i.e.
labelled mitochondria were distributed unevenly within
the cytoplasm (data not shown). Mitochondria distribu-
tion in oocytes from the IL-1β  group was more
homogeneous with labelled mitochondria distributed
evenly throughout the cytoplasm (data not shown).
Discussion
The aim of the present work was to analyze in vivo the
effect of IL-1β  and IL-1RA, after their intrafollicular injec-
tion into the preovulatory follicle. In experiment 1, ovula-
tion and embryo development were studied. In
experiment 2, the effect of IL-1β  on oocyte nuclear and
cytoplasmic maturation was investigated.
Table 1: Percentage of embryos after intrafollicular administration of IL-1β  or IL-1RA in equine dominant follicles.
Number of injected follicles Percent of embryos
PBS i.f., saline i.v. (negative control group) 12 67 (8/12)a
IL-1RA i.f., saline i.v. (IL-1RA group) 12 25 (3/12)b
IL-1β  i.f., saline i.v. (IL-1β  group) 13 23 (3/13)b
PBS i.f., CEG i.v. (positive control group) 12 67 (8/12)a
IL-1RA i.f., CEG i.v. (IL-1RA/CEG group) 13 23 (3/13)b
PBS, Phosphate buffer saline; CEG, crude equine gonadotropin; IL-1β , interleukin 1 beta; IL-1RA, interleukin 1 receptor antagonist; i.f., 
intrafollicular; i.v., intravenous. a and b are significantly different (p < 0.05).
Table 2: Number of punctured follicles, percentage of recovered cumulus-oocyte complexes, and percentage of degenerated, 
immature, metaphase I and metaphase II oocytes in each group.
COCs Oocytes
Number of injected-
punctured follicles
Percent of recovery Percent of DEG Percent of immature Resumption of 
meiosis
PBS i.f., CEG i.v. 23 91 (21/23)a 19 (4/21) 0 (0/21) 81 (17/21)a
IL-1β  i.f., saline i.v. 25 80 (20/25)a 20 (4/20) 20 (4/20) 60 (12/20)ab
PBS i.f., saline i.v. 15 73 (11/15)a 27 (3/11) 27 (3/11) 45 (5/11)b
PBS, Phosphate buffer saline; CEG, crude equine gonadotropin; IL-1β , interleukin 1 beta; i.f., intrafollicular; i.v., intravenous; DEG, degenerated; MI 
metaphase I; MII, metaphase II. a and b are significantly different (P < 0.05).Reproductive Biology and Endocrinology 2005, 3:26 http://www.rbej.com/content/3/1/26
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Cortical granules localization on serial optical sections in equine oocytes after intrafollicular injection of PBS (A) or IL-1β  (B)  and intravenous injection of CEG (A) or saline (B) Figure 2
Cortical granules localization on serial optical sections in equine oocytes after intrafollicular injection of PBS (A) or IL-1β  (B) 
and intravenous injection of CEG (A) or saline (B). 1–6: different sections from the top of the oocyte to the bottom of the 
oocyte A) Cortical granules migration achieved: the majority of the cortical granules are lining the oolemma. B) No cortical 
granules migration: the cortical granules are located in the medullary zone, and no cortical granules are lining the oolemma; 
X40Reproductive Biology and Endocrinology 2005, 3:26 http://www.rbej.com/content/3/1/26
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The intrafollicular injection technique is an interesting
alternative to study the effect of a factor on oocyte and fol-
licle maturation. It has been used in different species like
rabbit [16], ewe [17], cow [18], rhesus monkey [19], and
mares [13,15,20,21]. In the mare, this approach needs no
surgery because the large size of the preovulatory follicle
and the presence of a tunica albuginea, which allows
injecting follicles with limited leakage by using the trans-
vaginal ultrasound echo-guided method. In the present
work, 103 preovulatory follicles were successfully injected
and only 5 suffered serious damage.
In our study, 1 µg IL-1β  was injected in the follicle. This
dose was chosen regarding a dose-dependent study that
had been performed in vitro [22], and tested in vivo [13].
Similarly, the dose of IL-1RA we used in the present study
(5 µg) was chosen in accordance to a previous in vivo
study [13] where 1 µg IL-1RA had no effect.
We demonstrated in the present work, that the intrafollic-
ular injection of IL-1β  induced synchronized ovulations.
Actually, IL-1β  gave the same result, in terms of ovulation
distribution, as an i.v. injection of CEG [14]. This observa-
tion is in accordance with the recent work performed by
Martoriati et al. [13]. CEG is a pituitary extract used to
induce ovulation in the mare. By its LH activity, CEG is
used to give a precise timing of ovulation. It is preferen-
tially used in this specie instead of hCG, which is known
to induce immunoreaction after successive injections.
Although, the mechanisms by which IL-1 regulates follic-
ular maturation is unclear, our observations suggest that
IL-1 system could be involved in periovulatory events.
Thus, the mechanism of action of IL-1β  remains to be elu-
cidated, but we can hypothesize that the increase in IL-1β
intrafollicular level after injection may mimics the local
preovulatory events that precede ovulation.
That hypothesis explains why we constituted the IL-1RA-
CEG group, in which the intrafollicular injection of IL-
1RA would be able to block the CEG effect. After such
treatment (IL-1RA i.f. and CEG i.v.), we observed that half
of mares ovulated more than 47 h after injections. In such
mares, we can conclude either that CEG had no effect
(that is unlikely at this rate), or that the intrafollicular
injection of IL-1RA at the dose we used, inhibited the ovu-
latory effect of CEG. Other mares from this group ovu-
lated between 31 and 47 h after injection. In these mares
and in our experimental conditions, IL-1RA did not
inhibit the CEG ovulatory effect. These mares would prob-
ably had the process of ovulation engaged (i.e. increase in
the endogenous plasmatic concentration of LH) before IL-
1RA and CEG injections. The data we obtained from the
IL-1RA-CEG group are in accordance with a previous
study performed in the rat, that showed a time-dependent
inhibition of hCG-induced ovulation by IL-1RA [23].
As demonstrated in the present work, 60% of the oocytes
collected 38 h after IL-1β  intrafollicular injection dis-
played resumption of meiosis. This rate only tends to be
higher than that of the negative control group (p < 0,1).
This result is consistent with our previous result obtained
in the mare (57%) [13]. Taken together, both studies
imply a positive effect of IL-1β  on equine oocyte nuclear
maturation.
Considering this result, it was then questionable if ovu-
lated mature equine oocytes obtained after an intrafollic-
ular injection of IL-1β  were able to be fertilized. The very
low rate of embryo development that we observed in our
study after IL-1β  intrafollicular injection (25%) leads us to
hypothesize that IL-1β  may have a negative effect on
oocyte quality.
We tested this hypothesis by analyzing metaphase II (MII)
oocytes for cortical granules localization and mitochon-
dria distribution as criteria for cytoplasmic maturation. To
our knowledge, this is the first study of the effect of IL-1β
on oocyte cytoplasmic maturation that has been per-
formed in vivo in any species. In several mammals, it has
been reported that cortical granules are mainly lining the
oolemma of oocytes at the time of ovulation (in sheep
[24] ; in bovine [25-27] ; in equine [28]). In our study,
cortical granules migration was achieved or in progress in
most MII oocytes from the positive control group (CEG
group). In contrast, cortical granules did not line the
oolemma in most MII oocytes from IL-1β  injected follicle,
but remained homogeneously distributed in the
cytoplasm. This data suggests that in our study, IL-1β  was
unable to induce cortical granules migration, and thus, to
be fully involved in oocyte cytoplasmic maturation. Addi-
tional factors may be required for cortical granules
migration.
The distribution of mitochondria in MII oocytes was stud-
ied as a second criterion of cytoplasmic maturation. Two
mitochondrial distribution patterns were observed in
equine oocytes. The oocytes from the positive control
group (CEG group) displayed a clustering of mitochon-
dria around cytoplasmic vacuoles (heterogeneous
pattern), which observation is in accordance with previ-
ous studies (bovine [29] ; human [30,33,34] ; porcine
[31,32]). The second mitochondrial distribution pattern
that we observed mainly concerned oocytes from the IL-
1β  group. In these oocytes, mitochondria displayed a
homogeneous distribution. Such a homogeneous pattern
of mitochondria had previously been observed in imma-
ture porcine oocytes [32]. This data suggests that in our
experimental conditions, IL-1β  is unable to induce the
remodelling of mitochondria that occurs during oocyte
maturation.Reproductive Biology and Endocrinology 2005, 3:26 http://www.rbej.com/content/3/1/26
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All in all, whereas IL-1β  seems to be able to act on resump-
tion of meiosis, it is not sufficient for complete oocyte
cytoplasmic maturation, at least in the mare.
To be fertilized, an oocyte has to be mature up to his
nucleus and his cytoplasm. Thus, we could propose that
the low number of embryos conceived after IL-1β  intrafol-
licular injection could be probably due to an abnormal
cytoplasmic maturation of oocytes. This result seems at
odds with a previous study performed on perfused rabbit
ovary, in which IL-1β  facilitated fertilization [12].
However, these authors reported that most of fertilized
oocytes were arrested at the four-cell stage. Regarding this
findings, two hypothesis can be proposed to explain our
results. The first one is that IL-1β  is able to act on resump-
tion of meiosis, but cannot bring about cytoplasmic mat-
uration. The consequence is that oocytes are not suitable
for fertilization. The second hypothesis is that IL-1β  may
exert a cytotoxic effect on oocytes, that would allow ferti-
lization but prevent subsequent embryonic development.
In our study, pregnancy diagnosis was performed 14 days
after ovulation, that do not allow to verify one of these
two hypothesis. To alleviate this problem, in vitro fertili-
zation (IVF) could be performed on IL-1β -induced
matured oocyte.
Conclusion
In conclusion, the mechanism by which IL-1β  acts at the
ovarian level is unclear, and the present data tend to dem-
onstrate that IL-1β  alone is not able to promote cytoplas-
mic maturation of equine oocyte, and thus to allow
embryo development. Nevertheless, IL-1β  may play an
essential role in the physiology of equine oocytes by act-
ing on meiosis resumption as well as in the ovarian func-
tion by inducing ovulation.
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